{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:59:55Z","timestamp":1779217195029,"version":"3.51.4"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>This case report describes a rare situation in which a patient with schizophrenia and metastatic breast cancer experienced acute liver failure and hemolytic anemia caused by an overdose of quetiapine and aripiprazole. On the day of admission, the patient received lipid emulsion infusion, continuous renal replacement therapy (CRRT), and blood perfusion. After these treatments, the patient\u2019s consciousness improved from mild coma to full awareness. However, 48 hours after admission, the patient developed hemolytic anemia and acute liver failure. Following supportive treatments like plasma exchange, bilirubin adsorption, washed red blood cell transfusion, and low-dose dexamethasone for inflammation, the patient recovered and was discharged. This is the first reported case of hemolytic anemia and acute liver failure caused by mixed toxicity of quetiapine and aripiprazole in an adult patient. We analyze the characteristics of this case to enhance awareness of toxicity from atypical antipsychotics like quetiapine and aripiprazole, and to heighten vigilance regarding the potential risks of combined medication in patients with underlying liver disease, thereby improving the success rate of treatment.<\/jats:p>","DOI":"10.3389\/fpsyt.2026.1782761","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:48:29Z","timestamp":1776059309000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute liver failure and hemolytic anemia induced by quetiapine and aripiprazole overdose in a patient with schizophrenia and metastatic breast cancer: a unique case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Hua","family":"Zhong","sequence":"first","affiliation":[{"name":"Emergency Department, Liuyang People\u2019s Hospital","place":["Liuyang, Hunan, China"]},{"name":"Emergency Department, Liuyang People\u2019s Hospital","place":["Changsha, Hunan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Emergency Department, Liuyang People\u2019s Hospital","place":["Liuyang, Hunan, China"]},{"name":"Emergency Department, Liuyang People\u2019s Hospital","place":["Changsha, Hunan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3282f8e3a0","article-title":"Drug-induced liver injury: hepatotoxicity of quetiapine revisited","volume":"20","author":"Shpaner","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.23505","article-title":"Drug-induced liver injury: mechanisms and test systems","volume":"33","author":"Bissell","year":"2001","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006625.pub3","article-title":"Quetiapine versus other atypical antipsychotics for schizophrenia","volume":"2013","author":"Asmal","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40360-024-00782-2","article-title":"Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS)","volume":"25","author":"He","year":"2024","journal-title":"BMC Pharmacol Toxicol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2010.10091292","article-title":"Fatal hepatotoxicity in an elderly patient receiving low-dose quetiapine","volume":"168","author":"Naharci","year":"2011","journal-title":"Am J Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200412000-00029","article-title":"Subfulminant liver failure associated with quetiapine","volume":"16","author":"El Hajj","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.12.1773","article-title":"Aripiprazole: profile on efficacy and safety","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/60.23.2437","article-title":"Aripiprazole","volume":"60","author":"Winans","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1081\/clt-53097","article-title":"Aripiprazole (abilify) overdose in a child","volume":"43","author":"Seifert","year":"2005","journal-title":"Clin Toxicol (Phila)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e318196faaf","article-title":"Prolonged toxicity in a 2-year-old after accidental ingestion of aripiprazole","volume":"25","author":"Melhem","year":"2009","journal-title":"Pediatr Emerg Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0367-y","article-title":"Aripiprazole and acute extrapyramidal symptoms in children and adolescents: A meta-analysis","volume":"30","author":"Bernagie","year":"2016","journal-title":"CNS Drugs"},{"key":"B13","first-page":"201","article-title":"Malignant syndrome","volume":"16","author":"Aripiprazole","year":"2007","journal-title":"Prescr Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/070674370505000318","article-title":"Aripiprazole-induced seizure","volume":"50","author":"Malik","year":"2005","journal-title":"Can J Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001053","article-title":"Quetiapine poisoning and factors influencing severity","volume":"39","author":"Peridy","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.03.016","article-title":"Acute quetiapine overdose in adults: a 5-year retrospective case series","volume":"52","author":"Ngo","year":"2008","journal-title":"Ann Emerg Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0736-4679(99)00128-6","article-title":"Acute quetiapine poisoning","volume":"17","author":"Hustey","year":"1999","journal-title":"J Emerg Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2012.06.001","article-title":"Quetiapine-induced hepatocellular damage","volume":"53","author":"Lin","year":"2012","journal-title":"Psychosomatics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105056668","article-title":"Switching antipsychotics: an updated review with a focus on quetiapine","volume":"20","author":"Weiden","year":"2006","journal-title":"J Psychopharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158292","article-title":"Antipsychotic drug aripiprazole protects liver cells from oxidative stress","volume":"23","author":"Kramar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B21","first-page":"FF4R","article-title":"Kongenital trombotisk trombocytopen purpura \u2013 ett fall med atypisk bild uppt\u00e4ckt i vuxen \u00e5lder [A case of quetiapine-induced congenital thrombotic thrombocytopenic purpura, atypical phenotype diagnosed in adulthood","volume":"116","author":"Gustafsson","year":"2019","journal-title":"Lakartidningen"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G067","article-title":"Thrombotic thrombocytopenic purpura associated with quetiapine","volume":"39","author":"Huynh","year":"2005","journal-title":"Ann Pharmacother"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2018.16.4.501","article-title":"Quetiapine induced autoimmune hemolytic anemia in a child patient: a case report","volume":"16","author":"Ar\u0131c\u0131","year":"2018","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"B25","unstructured":"PubChem compound summary for CID 60795, aripiprazole\n          \n          2026"},{"key":"B26","unstructured":"PubChem compound summary for CID 5002, quetiapine\n          \n          2026"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001687","article-title":"Recurrence of symptoms or re-elevation of drug concentration after termination of lipid emulsion treatment for drug toxicity: analysis of case reports and systematic review","volume":"31","author":"Hwang","year":"2024","journal-title":"Am J Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4097\/kja.23031","article-title":"Mechanisms underlying lipid emulsion resuscitation for drug toxicity: a narrative review","volume":"76","author":"Lee","year":"2023","journal-title":"Kor J Anesthesiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12111930","article-title":"Therapeutic dosage of antipsychotic drug aripiprazole induces persistent mitochondrial hyperpolarisation, moderate oxidative stress in liver cells, and haemolysis","volume":"12","author":"Pirc Marolt","year":"2023","journal-title":"Antioxid (Basel)"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1782761\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:48:32Z","timestamp":1776059312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1782761\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":29,"alternative-id":["10.3389\/fpsyt.2026.1782761"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1782761","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1782761"}}